Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

2.130

-0.060 (-2.74%)

At close: Aug 28, 2026, 4:00 PM EDT

2.148

+0.018 (0.85%)

After-hours: Aug 28, 2026, 7:59 PM EDT

Tenax Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	117.98	97.57	94.85	9.79	2.12	5.58
Cash & Short-Term Investments	117.98	97.57	94.85	9.79	2.12	5.58
Cash Growth	11.87%	2.86%	868.66%	361.09%	-61.97%	-16.82%
Prepaid Expenses	3.42	5.64	1.77	1.64	0.74	0.11
Other Current Assets	0.27	1.02	0.06	0.25	0.35	-
Total Current Assets	121.66	104.23	96.69	11.68	3.21	5.69
Property, Plant & Equipment	-	-	-	-	0.19	0.29
Other Long-Term Assets	-	-	-	0	0.01	0.01
Total Assets	121.66	104.23	96.69	11.69	3.4	5.99

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.8	6.04	3.16	2.07	0.45	0.86
Accrued Expenses	1.28	1.12	1.54	1.01	0.66	0.6
Short-Term Debt	-	-	-	0.5	0.62	-
Current Portion of Leases	-	-	-	-	0.12	0.11
Total Current Liabilities	8.07	7.16	4.69	3.59	1.85	1.56
Long-Term Leases	-	-	-	-	0.06	0.18
Total Liabilities	8.07	7.16	4.69	3.59	1.91	1.75

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	-	-	0	0
Additional Paid-In Capital	514.56	464.52	406.85	305.35	291.03	282.74
Retained Earnings	-400.97	-367.45	-314.86	-297.25	-289.54	-278.49
Total Common Equity	113.59	97.07	91.99	8.1	1.49	4.24
Shareholders' Equity	113.59	97.07	91.99	8.1	1.49	4.24
Total Liabilities & Equity	121.66	104.23	96.69	11.69	3.4	5.99

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	0.5	0.81	0.29
Net Cash (Debt)	117.98	97.57	94.85	9.29	1.32	5.29
Net Cash Growth	11.87%	2.86%	920.89%	606.12%	-75.14%	-17.40%
Net Cash Per Share	2.67	2.49	6.21	37.40	71.55	411.57
Filing Date Shares Outstanding	57.28	50.3	35.85	1.96	0.35	0.02
Total Common Shares Outstanding	51.81	42.42	35.3	0.3	0.03	0.02
Working Capital	113.59	97.07	91.99	8.1	1.36	4.13
Book Value Per Share	2.19	2.29	2.61	27.15	52.11	269.43
Tangible Book Value	113.59	97.07	91.99	8.1	1.49	4.24
Tangible Book Value Per Share	2.19	2.29	2.61	27.15	52.11	269.43

SEC Filings: 10-K · 10-Q